郑州微飒生物科技有限责任公司 咨询热线:0371-88821766
行业动态

行业动态

追踪行业前沿,洞察产业趋势

药效评价Functionally selective dopamine D₂, D₃ receptor partial agonists.

期刊:Journal of medicinal chemistry发表年份:2014作者:Dorothee Möller; Ralf C Kling; Marika Skultety; Kristina Leuner; Harald Hübner; Peter Gmeiner

药效评价Verification of a new biocompatible single-use film formulation with optimized additive content for multiple bioprocess applications.

期刊:Biotechnology progress发表年份:2014作者:Elke Jurkiewicz; Ute Husemann; Gerhard Greller; Magali Barbaroux; Christel Fenge

药效评价An allosteric switch for pro-HGF/Met signaling using zymogen activator peptides.

期刊:Nature chemical biology发表年份:2014作者:Kyle E Landgraf; Micah Steffek; Clifford Quan; Jeffrey Tom; Christine Yu; Lydia Santell; Henry R Maun; Charles Eigenbrot; Robert A Lazarus

药效评价Novel oxazolo-oxazole derivatives of FTY720 reduce endothelial cell permeability, immune cell chemotaxis and symptoms of experimental autoimmune encephalomyelitis in mice.

期刊:Neuropharmacology发表年份:2014作者:Faik Imeri; Daniel Fallegger; Aleksandra Zivkovic; Stephanie Schwalm; Gaby Enzmann; Kira Blankenbach; Dagmar Meyer zu Heringdorf; Thomas Homann; Burkhard Kleuser; Josef Pfeilschifter; Britta Engelhardt; Holger Stark; Andrea Huwiler